Neurol. praxi. 2010;11(1):56-58

Stroke in diabetic patients

doc.MUDr.Jaromír Chlumský, Ph.D., prof.MUDr.Jindra Perušičová, DrSc., prof.MUDr.Milan Kvapil, CSc.
Interní klinika 2. LF UK a FN Motol, Praha

It is estimated that the risk of stroke is increased by 1.5–3 fold for patients with diabetes. Diabetes also doubles the risk of stroke recurrence,

and stroke outcomes are significantly worse among patients with diabetes with increased mortality, more residual neurological deficit

and longer hospital stays. Diabetes increases the risk of ischaemic stroke more than haemorrhagic stroke. Despite the higher prevalence

of stroke in patients with diabetes, they have been shown to be less likely to develop transient ischaemic attack. Tight glycaemic control

is recommended to prevent microvascular complications, but its benefits on macrovascular disease and stroke risk are still unproven.

The management of patients with diabetes and acute stroke should include multifactorial intervention – antihypertensive, lipid-lowering

and antiplatelet agents and, where appropriate, surgical intervention.

Keywords: ischemic stroke, diabetes, treatment

Published: March 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chlumský J, Perušičová J, Kvapil M. Stroke in diabetic patients. Neurol. praxi. 2010;11(1):56-58.
Download citation

References

  1. Bartolucci AA, Howard G. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin. Am J Cardiol 2006; 98: 746-750. Go to original source... Go to PubMed...
  2. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354: 1706-1717. Go to original source... Go to PubMed...
  3. Gentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med 2006; 13: 174-180. Go to original source...
  4. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-259. Go to original source...
  5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853.
  6. Jorgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patiens with diabetes: the Copenhagen Stroke Study. Stroke 1994; 25: 1977-1984. Go to original source... Go to PubMed...
  7. Karapanayiotides T, Piechowski-Jozwiak B, van Melle G, Bogousslavsky J, Devuyst G. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology 2004; 62: 1558-1562. Go to original source... Go to PubMed...
  8. Kissela BM, Khoury J, Kleindorfer D, Woo D, Schneider A, Alwell K, Miller R, Ewing I, Moomaw CJ, Szaflarski JP, Gebel J, Shukla R, Broderick JP. Epidemiology of ischemic stroke in patients with diabetes: the Greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 2005; 28: 355-359. Go to original source... Go to PubMed...
  9. Lithner F, Asplund K, Eriksson S, Hagg E, Strand T, Wester PO. Clinical characteristics in diabetic stroke patients. Diabetes Metab 1988; 14: 15-19.
  10. Lukovits TG, Mazzone Th, Gorelick PB. Diabetes mellitus and cerebrovascular disease. Neuroepidemiology 1999; 18: 1-14. Go to original source... Go to PubMed...
  11. Maejima K, Nakano S, Himeno M, Tsuda S, Makiishi H, Ito T, Nakagawa A, Kigoshi T, Ishibashi T, Nishio M, Uchida K. Increased basal levels of plasma nitric oxide in type 2 diabetic subjects: relationship to microvascular complications. J Diabetes Complications 2001; 15: 135-143. Go to original source... Go to PubMed...
  12. Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PW. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 2000; 283: 221-228. Go to original source... Go to PubMed...
  13. Mooradian AD. Cardiovascular disease in type 2 diabetes mellitus: current management guidelines. Arch Intern Med 2003; 163: 33-40. Go to original source... Go to PubMed...
  14. Nassief A, Marsh JD. Statin therapy for stroke prevention. Stroke 2008; 39: 1042-1048. Go to original source... Go to PubMed...
  15. Pedersen O, Gaede P. Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study. Metabolism 2003; 52: 19-23. Go to original source... Go to PubMed...
  16. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-1041. Go to original source... Go to PubMed...
  17. Ribo M, Molina C, Montaner J, Rubiera M, Delgado-Mederos R, Arenillas JF, Quintana M, Alvarez-Sabin J. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke 2005; 36: 1705-1709. Go to original source... Go to PubMed...
  18. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol. 2009; 53: 298-304. Go to original source... Go to PubMed...
  19. Teal PA. Recent clinical trial results with antiplatelet therapy: implications in stroke prevention. Cerebrovasc Dis 2004; 17: 6-10. Go to original source... Go to PubMed...
  20. Wannamethee SG, Shaper AG, Ebrahim S. HDL-cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke 2000; 31: 1882-1888. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.